UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.352

Sortiert nach

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

Leukemia, 2019-12, Vol.33 (12), p.2974-2978

2019

Volltextzugriff (PDF)

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Leukemia, 2010-04, Vol.24 (4), p.699-705

2010

Volltextzugriff (PDF)

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Leukemia, 2017-11, Vol.31 (11), p.2347-2354

2017

Volltextzugriff (PDF)

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

Leukemia, 2013-10, Vol.27 (10), p.2023-2031

2013

Volltextzugriff (PDF)

A reaction progress variable modeling approach for non-ideal multiphase explosives

International journal of multiphase flow, 2012-06, Vol.42, p.128-151

2012

Volltextzugriff (PDF)

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Leukemia, 2012-07, Vol.26 (7), p.1713-1717

2012

Volltextzugriff (PDF)

Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia

Leukemia, 2011-02, Vol.25 (2), p.367-371

2011

Volltextzugriff (PDF)

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

Oncogene, 2013-04, Vol.32 (14), p.1784-1793

2013

Volltextzugriff (PDF)

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

Leukemia, 2017-01, Vol.31 (1), p.34-39

2017

Volltextzugriff (PDF)

Breast cancer resistance protein (BCRP MXR ABCG2) in acute myeloid leukemia: discordance between expression and function

Leukemia, 2004-07, Vol.18 (7), p.1252-1257

2004

Volltextzugriff (PDF)

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

Leukemia, 2011-05, Vol.25 (5), p.800-807

2011

Volltextzugriff (PDF)

Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms

Leukemia research, 2018-08, Vol.71, p.82-88

2018

Volltextzugriff (PDF)

Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3767-3775

1999

Volltextzugriff (PDF)

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Blood, 2001-06, Vol.97 (11), p.3574-3580

2001

Volltextzugriff (PDF)

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

Leukemia, 2017-06, Vol.31 (6), p.1278-1285

2017

Volltextzugriff (PDF)

Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients

Bone marrow transplantation (Basingstoke), 2003-08, Vol.32 (4), p.405-410

2003

Volltextzugriff (PDF)

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461

Journal of clinical oncology, 1997-02, Vol.15 (2), p.466-475

1997

Volltextzugriff (PDF)

Serotonin syndrome caused by interaction between citalopram and fentanyl

Journal of clinical pharmacy and therapeutics, 2007-04, Vol.32 (2), p.199-202

2007

Volltextzugriff (PDF)

3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant

Hematological oncology, 2023-06, Vol.41 (S2), p.520-521

2023

Volltextzugriff (PDF)

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

Leukemia, 2014-06, Vol.28 (6), p.1252-1258

2014

Volltextzugriff (PDF)

HLA-DR antigen-negative acute myeloid leukemia

Leukemia, 2003-04, Vol.17 (4), p.707-715

2003

Volltextzugriff (PDF)

Modeling heterogeneous energetic materials at the mesoscale

Thermochimica acta, 2002-02, Vol.384 (1), p.351-367

Baer, M.R.

2002

Volltextzugriff (PDF)

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics

Cancer research (Chicago, Ill.), 1998, Vol.58 (1), p.55-59

1998

Volltextzugriff (PDF)

A compact strip-line pulsed power generator for isentropic compression experiments

Review of scientific instruments, 2008-01, Vol.79 (1), p.013903-013903

2008

Volltextzugriff (PDF)

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation : possible beneficial use of low molecular weight heparin

Bone marrow transplantation (Basingstoke), 2001-03, Vol.27 (6), p.627-633

2001

Volltextzugriff (PDF)

1 – 25 von 2.352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.926)
Mit Volltextzugriff
(2.053)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.383)
Life Sciences & Biomedicine
(958)
Humans
(826)
Female
(509)
Male
(479)
Biological And Medical Sciences
(420)
Adult
(335)
Medical Sciences
(319)
Middle Aged
(318)
Physical Sciences
(312)
Physics
(245)
Aged
(223)
Animals
(221)
Technology
(179)
Oncology
(159)
Chemistry
(126)
Fundamental And Applied Biological Sciences. Psychology
(118)
Hematology
(115)
Adolescent
(114)
Exact Sciences And Technology
(110)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia

A reaction progress variable modeling approach for non-ideal multiphase explosives

The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia

Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)

Breast cancer resistance protein (BCRP MXR ABCG2) in acute myeloid leukemia: discordance between expression and function

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms

Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia

Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461

Serotonin syndrome caused by interaction between citalopram and fentanyl

3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant

GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

HLA-DR antigen-negative acute myeloid leukemia

Modeling heterogeneous energetic materials at the mesoscale

Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics

A compact strip-line pulsed power generator for isentropic compression experiments

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation : possible beneficial use of low molecular weight heparin

Suchergebnisse filtern